Actively Recruiting
BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")
Led by Inna Chen, MD · Updated on 2023-03-01
5000
Participants Needed
1
Research Sites
1408 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
No validated biomarkers to identify PC at an early stage and to predict treatment outcomes in the individual patient exist. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.
CONDITIONS
Official Title
BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years
- Histologically verified pancreatic cancer (ductal adenocarcinoma) or ampullary adenocarcinoma in a resected specimen
- Histopathological confirmation of carcinoma in patients not undergoing surgery with clinical and radiological features consistent with pancreatic cancer
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Herlev & Gentofte Hospital
Herlev, Denmark, 2730
Actively Recruiting
Research Team
J
Julia Sidenius Johansen, MD, DMsc
CONTACT
I
Inna Markovna Chen, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here